2000
DOI: 10.1111/j.1346-8138.2000.tb02251.x
|View full text |Cite
|
Sign up to set email alerts
|

A Case of Subcorneal Pustular Dermatosis Treated with Tacalcitol (1α,24‐Dihydroxyvitamin D3)

Abstract: We report a case of subcorneal pustular dermatosis (SPD) treated with tacalcitol (1alpha,24-Dihydroxyvitamin D3) ointment. A 77-year-old male had had asymptomatic, superficial, grouped pustules in annular patterns with mild background erythema for six years which affected his axillae and bilateral groin. A diagnosis of SPD was made. Topical vitamin D3 (tacalcitol) was applied to the lesion of SPD and its clinical effectiveness was assessed. Within one month, symptoms in the lesion treated with tacalcitol ointm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0
1

Year Published

2004
2004
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(10 citation statements)
references
References 15 publications
0
9
0
1
Order By: Relevance
“…In the absence of irritation, topical vitamin D is well tolerated and may be helpful in the treatment of other neutrophilic skin diseases such as erosive pustular dermatosis of the scalp (26) or subcorneal pustular dermatosis (27). Nevertheless, the different individual efficiency of any regimen must never be underestimated.…”
Section: Discussionmentioning
confidence: 98%
“…In the absence of irritation, topical vitamin D is well tolerated and may be helpful in the treatment of other neutrophilic skin diseases such as erosive pustular dermatosis of the scalp (26) or subcorneal pustular dermatosis (27). Nevertheless, the different individual efficiency of any regimen must never be underestimated.…”
Section: Discussionmentioning
confidence: 98%
“…Subcorneal pustular dermatosis (SPD) is a rare, chronic, benign and relapsing pustular eruption of unknown aetiology and pathogenesis 1 . Although many therapeutic agents have been proposed, few resistant or intolerant patients have been reported 1,3–9 …”
Section: Comparison Of Spd Cases Treated With Cyclosporin a In The LImentioning
confidence: 99%
“…Dapsone (50–200 mg/day), the main agent in SPD, inhibits the cytotoxic effects of peripheral neutrophils and may, as sulphapyridines, cause life‐threatening side‐effects including methaemoglobinaemia and haemolytic anaemia 1 . Corticosteroids, tacalcitol, etretinate, PUVA, acitretin, mebhydroline, ketoconazole, colchicine, mizoribine, minocycline, vitamine E, niacin and, recently, infliximab have also been proposed 1,3–9 …”
Section: Comparison Of Spd Cases Treated With Cyclosporin a In The LImentioning
confidence: 99%
See 2 more Smart Citations